Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Flu Vaccine Manufacturing With Canine Kidney Cells To Be Discussed By Committee In November

This article was originally published in The Pink Sheet Daily

Executive Summary

FDA's vaccines advisory committee will discuss Madin-Darby canine kidney cells for flu vaccine manufacturing Nov. 16. Solvay submitted a drug master file for a canine cell-based influenza vaccine in June.

You may also be interested in...



Adult Pneumococcal Conjugate Vaccine Approvals Should Not Be Based On Immunologic Data, Advisory Cmte. Says

Vaccine committee upholds FDA opinion that clinical efficacy endpoint studies should be basis of licensure for pneumococcal conjugate vaccine in adults.

Adult Pneumococcal Conjugate Vaccine Approvals Should Not Be Based On Immunologic Data, Advisory Cmte. Says

Vaccine committee upholds FDA opinion that clinical efficacy endpoint studies should be basis of licensure for pneumococcal conjugate vaccine in adults.

Adult Pneumococcal Vaccine Immune Response Studies Could Be Basis For Accelerated Approval, FDA Suggests

FDA’s Vaccines & Related Biological Products Advisory Committee will consider proposals from Wyeth and GlaxoSmithKline for approval based on antibody titer studies at Nov. 17 meeting.

Related Content

Topics

UsernamePublicRestriction

Register

PS061125

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel